Global Liposomes Drug Delivery Market Status and Outlook 2018-2025

July 2018 | 188 pages | ID: G423527D752EN
99Strategy

Abstracts

Report Snapshot

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1: Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2: Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3: Product Segment Overview and Market Status
Part 4: Application / End-User Segment Overview and Market Status
Part 5: Region Segment Overview and Market Status
Part 6: Product & Application Segment Production & Demand by Region
Part 7: Market Forecast by Product, Application & Region
Part 8: Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9: Market Competition and Environment for New Entrants
Part 10: Conclusion

Market Segment as follows:

Key Companies

• Johnson & Johnson
• Gilead Sciences
• Luye Pharma
• Sun Pharmaceutical
• Pacira
• Fudan-Zhangjiang
• Sigma-Tau Group
• Teva Pharmaceutical
• CSPC
• Novartis
• Crucell
• Celsion Corporation
• Kingond Pharm
• Shanghai New Asia
• Spectrum Pharmaceuticals

Market by Type

• Liposomal doxorubicin
• Liposomal Amphoteracin B
• Liposomal Paclitaxel
• Others

Market by Application

• Fungal Infection Therapy
• Cancer Therapy ( Tumor therapy)
• Others

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Liposomes Drug Delivery Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Liposomal doxorubicin
  3.1.2 Liposomal Amphoteracin B
  3.1.3 Liposomal Paclitaxel
  3.1.4 Others
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Fungal Infection Therapy
  4.1.2 Cancer Therapy ( Tumor therapy)
  4.1.3 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sultan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Liposomal doxorubicin Production by Region
    6.1.1.2 Liposomal Amphoteracin B Production by Region
    6.1.1.3 Liposomal Paclitaxel Production by Region
    6.1.1.4 Others Production by Region
  6.1.2 Production by Application
    6.1.2.1 Fungal Infection Therapy Production by Region
    6.1.2.2 Cancer Therapy ( Tumor therapy) Production by Region
    6.1.2.3 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Liposomal doxorubicin Demand by Region
    6.2.1.2 Liposomal Amphoteracin B Demand by Region
    6.2.1.3 Liposomal Paclitaxel Demand by Region
    6.2.1.4 Others Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Fungal Infection Therapy Demand by Region
    6.2.2.2 Cancer Therapy ( Tumor therapy) Demand by Region
    6.2.2.3 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Johnson & Johnson
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Gilead Sciences
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Luye Pharma
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Sun Pharmaceutical
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Pacira
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Fudan-Zhangjiang
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Sigma-Tau Group
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Teva Pharmaceutical
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 CSPC
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 Novartis
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 Crucell
8.12 Celsion Corporation
8.13 Kingond Pharm
8.14 Shanghai New Asia
8.15 Spectrum Pharmaceuticals

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Liposomes Drug Delivery Industry Dynamics & Regulations List
Table Global Liposomes Drug Delivery Sales Revenue, Cost and Margin, 2015-2018E
Table Global Liposomes Drug Delivery Market Status by Type 2015-2018E, in USD Million
Table Global Liposomes Drug Delivery Market Status by Application 2015-2018E, in USD Million
Table Global Liposomes Drug Delivery Market Status by Application 2015-2018E, in Volume
Table Global Liposomes Drug Delivery Market by Region 2015-2018E, in USD Million
Table Global Liposomes Drug Delivery Market Share by Region in 2018, in USD Million
Table Global Liposomes Drug Delivery Market by Region 2015-2018E, in Volume
Table Global Liposomes Drug Delivery Market Share by Region in 2018, in Volume
Table Liposomal doxorubicin Production Value by Region 2015-2018E, in USD Million
Table Liposomal doxorubicin Production Volume by Region 2015-2018E, in Volume
Table Liposomal Amphoteracin B Production Value by Region 2015-2018E, in USD Million
Table Liposomal Amphoteracin B Production Volume by Region 2015-2018E, in Volume
Table Liposomal Paclitaxel Production Value by Region 2015-2018E, in USD Million
Table Liposomal Paclitaxel Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Fungal Infection Therapy Production Value by Region 2015-2018E, in USD Million
Table Fungal Infection Therapy Production Volume by Region 2015-2018E, in Volume
Table Cancer Therapy ( Tumor therapy) Production Value by Region 2015-2018E, in USD Million
Table Cancer Therapy ( Tumor therapy) Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Liposomal doxorubicin Market Size by Region 2015-2018E, in USD Million
Table Liposomal doxorubicin Market Size by Region 2015-2018E, in Volume
Table Liposomal Amphoteracin B Market Size by Region 2015-2018E, in USD Million
Table Liposomal Amphoteracin B Market Size by Region 2015-2018E, in Volume
Table Liposomal Paclitaxel Market Size by Region 2015-2018E, in USD Million
Table Liposomal Paclitaxel Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table Fungal Infection Therapy Market Size by Region 2015-2018E, in USD Million
Table Fungal Infection Therapy Market Size by Region 2015-2018E, in Volume
Table Cancer Therapy ( Tumor therapy) Market Size by Region 2015-2018E, in USD Million
Table Cancer Therapy ( Tumor therapy) Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalLiposomes Drug Delivery Forecast by Type 2019F-2025F, in USD Million
Table Liposomes Drug Delivery Forecast by Type 2019F-2025F, in Volume
Table Liposomes Drug Delivery Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Liposomes Drug Delivery Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Liposomes Drug Delivery Market Forecast by Region 2019F-2025F, in USD Million
Table Liposomes Drug Delivery Market Forecast by Region 2019F-2025F, in Volume
Table Johnson & Johnson Information
Table Liposomes Drug Delivery Sales, Cost, Margin of Johnson & Johnson
Table Gilead Sciences Information
Table Liposomes Drug Delivery Sales, Cost, Margin of Gilead Sciences
Table Luye Pharma Information
Table Liposomes Drug Delivery Sales, Cost, Margin of Luye Pharma
Table Sun Pharmaceutical Information
Table Liposomes Drug Delivery Sales, Cost, Margin of Sun Pharmaceutical
Table Pacira Information
Table Liposomes Drug Delivery Sales, Cost, Margin of Pacira
Table Fudan-Zhangjiang Information
Table Liposomes Drug Delivery Sales, Cost, Margin of Fudan-Zhangjiang
Table Sigma-Tau Group Information
Table Liposomes Drug Delivery Sales, Cost, Margin of Sigma-Tau Group
Table Teva Pharmaceutical Information
Table Liposomes Drug Delivery Sales, Cost, Margin of Teva Pharmaceutical
Table CSPC Information
Table Liposomes Drug Delivery Sales, Cost, Margin of CSPC
Table Novartis Information
Table Liposomes Drug Delivery Sales, Cost, Margin of Novartis
Table Crucell Information
Table Liposomes Drug Delivery Sales, Cost, Margin of Crucell
Table Celsion Corporation Information
Table Liposomes Drug Delivery Sales, Cost, Margin of Celsion Corporation
Table Kingond Pharm Information
Table Liposomes Drug Delivery Sales, Cost, Margin of Kingond Pharm
Table Shanghai New Asia Information
Table Liposomes Drug Delivery Sales, Cost, Margin of Shanghai New Asia
Table Spectrum Pharmaceuticals Information
Table Liposomes Drug Delivery Sales, Cost, Margin of Spectrum Pharmaceuticals
Table Global Liposomes Drug Delivery Sales Revenue by Company 2015-2017, in USD Million
Table Global Liposomes Drug Delivery Sales Volume by Company 2015-2017, in Volume
Table Global Liposomes Drug Delivery Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Liposomes Drug Delivery Picture
Figure Liposomes Drug Delivery Industry Chain Diagram
Figure Global Liposomes Drug Delivery Sales Revenue 2015-2018E, in USD Million
Figure Global Liposomes Drug Delivery Sales Volume 2015-2018E, in Volume
Figure Global Liposomes Drug Delivery Market Status by Type 2015-2018E, in Volume
Figure North America Liposomes Drug Delivery Market Size and Growth 2015-2018E, in USD Million
Figure North America Liposomes Drug Delivery Market Size and Growth 2015-2018E, in Volume
Figure Europe Liposomes Drug Delivery Market Size and Growth 2015-2018E, in USD Million
Figure Europe Liposomes Drug Delivery Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Liposomes Drug Delivery Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Liposomes Drug Delivery Market Size and Growth 2015-2018E, in Volume
Figure South America Liposomes Drug Delivery Market Size and Growth 2015-2018E, in USD Million
Figure South America Liposomes Drug Delivery Market Size and Growth 2015-2018E, in Volume
Figure Middle East Liposomes Drug Delivery Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Liposomes Drug Delivery Market Size and Growth 2015-2018E, in Volume
Figure Africa Liposomes Drug Delivery Market Size and Growth 2015-2018E, in USD Million
Figure Africa Liposomes Drug Delivery Market Size and Growth 2015-2018E, in Volume
Figure Global Liposomes Drug Delivery Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Liposomes Drug Delivery Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Liposomes Drug Delivery Sales Price Forecast 2019F-2025F
Figure Global Liposomes Drug Delivery Gross Margin Forecast 2019F-2025F
Figure Global Liposomes Drug Delivery Sales Revenue by Company in 2018, in USD Million
Figure Global Liposomes Drug Delivery Price by Company in 2018
Figure Global Liposomes Drug Delivery Gross Margin by Company in 2018